МЕТАБОЛИКАЛЫҚ СИНДРОМЫ БАР НАУҚАСТАР ҚАНЫНЫҢ ЛИПИДТІК СПЕКТРІ ЖӘНЕ ЭРИТРОЦИТТЕР АГРЕГАЦИЯСЫ
Метаболикалық синдромы бар науқастарда Ашкинази әдісімен эритроциттердің агрегациялы қасиеттеріне лазер сәулелерінің әсерін зерттеу қанның реалогиялық қасиеттерінің жақсаруын көрсететін эритроциттер агрегациясы деңгейінің төмендеуін анықтады. Сонымен қатар, липидтік алмасу көрсеткіщтеріне лазердің жағымды әсері байқалды.
Толығырақ
2013 жыл | Шығарылым: 1 | Беттер: 63-64
AGGREGATION OF ERYTHROCYTES AND BLOOD LIPID SPECTRUM IN PATIENTS WITH METABOLIC SYNDROME
Study influence of laser rays on aggregating properties of red corpuscles by the method of Ashkinazy for patients with a metabolic syndrome allowed reveal the decline of red corpuscles aggregating degree, that specifies on the improvement of reologic blood properties. In parallel with this the positive effect of laser is marked on the indexes of lipid exchange.
Толығырақ
2013 жыл | Шығарылым: 1 | Беттер: 63-64
GENETIC VARIANTS IN LIPID-ASSOCIATED GENES IN THE KAZAKHSTANI COHORT WITH ATHEROSCLEROSIS AND HYPERTRIGLYCERIDEMIA
2025 жыл | Шығарылым: 5 | Беттер: 7-15
CLONAL HEMATOPOIESIS WITH INDETERMINATE POTENTIAL IN TET2 AND DNMT3A AMONG KAZAKHSTANI INDIVIDUALS WITH ATHEROSCLEROTIC DISEASE
2025 жыл | Шығарылым: 5 | Беттер: 16-23
PRELIMINARY ANALYSIS AND ASSESSMENT OF THE HEALTH STATUS OF THE DESCENDANTS OF PERSONS EXPOSED TO RADIATION, LIVING IN THE BESKARAGAI DISTRICT OF THE ABAY REGION
2025 жыл | Шығарылым: 5 | Беттер: 24-31
PRELIMINARY ANALYSIS OF THE HEALTH STATUS AND RADIATION DOSES OF RESIDENTS OF THE ABAY DISTRICT OF THE ABAY REGION, WHO ARE DESCENDANTS OF PERSONS EXPOSED TO RADIATION DUE TO NUCLEAR WEAPONS TESTS
2025 жыл | Шығарылым: 5 | Беттер: 32-39
TRENDS AND DISPARITIES IN CANCER MORBIDITY IN KAZAKHSTAN: A REGIONAL AND AGE-BASED ANALYSIS FOR 2014-2024
2025 жыл | Шығарылым: 5 | Беттер: 40-46
PROVIDING TRAUMA CARE DOCTORS SURGERY
The article discusses the presence of statistically significant differences in health care in related disciplines with surgery between physician’s district and municipal level. During the research, we had found a statistically significant association between the location of therapeutic and preventive organization in which medical assistance (city, district) and not providing specialized care for surgery doctor’s surgery. All within the framework of our study collected questionnaires from 84 respondents (out of 135 possible). The results showed that 100% of the respondents o...
Толығырақ
2014 жыл | Шығарылым: 2 | Беттер: 31-34
LATE EFFECTS AND ADAPTATION OF UNSPECIFIC PHAGOCYTIC RESISTANCE OF ORGANISM IRRADIATED BY SMALL DOSES OF GAMMА – IRRADIATION
In late period after action of small dose of gamma-irradiation and emotional stress high unspecific phagocytic resistance of organism appears in the all stages of adaptation syndrome.
Толығырақ
2014 жыл | Шығарылым: 2 | Беттер: 28-30
ADAPTATION OF HUMORAL LINK OF IMMUNE SYSTEM IN LATE PERIOD AFTER FRACTIONAL GAMMA-IRRADIOTION
In late period after fractional gamma-irradiation both in early and late periods of adaptation syndrome further deepening of depression in humoral link of immunity.
Толығырақ
2014 жыл | Шығарылым: 2 | Беттер: 25-27
CHANGES OF CONDITION OF LYMPHOID ORGANS OF IMMUNOGENESIS IN LANE PERIOD AFTER INFLUENCE OF FRACTIONAL DOZE OF GAMMA-IRRADIATION
In late period after general fractional gamma-irradiation mass, number of thymocytes in thymus and number of lymphoid cells in lymphatic nodes of small intestine are decreased.
Толығырақ
2014 жыл | Шығарылым: 2 | Беттер: 22-24
SUMMARY RISTOCETINUM FOR ANALYSIS OF VON WILLEBRAND FACTOR: DO WE ACTUALLY NEED IT?
Ristocetinum – cofactor analysis (R:Co) is the main method for estimation of von Willebrand factor activity at diagnostic of Willebrand diseases (WD). Nevertheless, this analysis is distinct with bad reproducibility and low sensibility at low rates of FWV and it is considerably time-consuming. In this paper, Lawrie and coauthor have evaluated the productivity of new immuno-turbidimetric analysis to define activity of FWV (INNOVANCE® VWF Ac., Siemens Healthcare Diagnostics, Marburg, Germany). In this analysis ristocetinum and thrombocytes are not use and changed with fra...
Толығырақ
2014 жыл | Шығарылым: 2 | Беттер: 20-22